$ADCT· SEC filing ·

ADCT Reports $22.3M Q4 Rev, $73.6M FY Rev, $261.3M Cash, LOTIS-5 2Q26 Data, Cash Runway to 2028

ADC Therapeutics SA · PHARMACEUTICAL PREPARATIONS · Now $3.40

Post-detection moves

1h
1d
3d
7d
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS